User:Blent/Seminar 07 fall: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 1: Line 1:
==Title==
==Title==
* Toward Personalized Medicine in BMI-based Methodology: A case study of [http://en.wikipedia.org/wiki/Carbamazepine Carbamazepine] and challenges in the future
* Toward Personalized Medicine in BMI-based Methodology: A case study of [http://en.wikipedia.org/wiki/Carbamazepine Carbamazepine] and challenges in the future
==Outlines (Sep 26, 2007)==
==Outlines (Sep 27, 2007)==
* case study #1: The First race-specific drug '''Bibil'''
* case study: CBZ-SJS
** [http://explore.pts.org.tw/p2.htm 公視 探索未知世界 第二集: 解毒生命密碼-基因與藥物過敏]
** [http://sa.ylib.com/news/newsshow.asp?FDocNo=438&CL=28 嚴重藥物過敏,可以預防 (科學人 2004 May)]
** [http://drug.doh.gov.tw/bulletin_cnt.php?PHPSESSID=bg6ksuvuq317fmk4runq4232b6&Pact=bulletin&id=160 我國個人化醫療跨出一大步,讓藥害救濟由事後救濟邁向事前預防 (行政院衛生署藥物資訊網)]
 
* case study: The First race-specific drug '''Bibil'''
** [http://www.liverx.org/2007/09/05/藥瓶裡的種族問題/ 活力藥師網番外篇-藥瓶裡的種族問題]
** [http://www.liverx.org/2007/09/05/藥瓶裡的種族問題/ 活力藥師網番外篇-藥瓶裡的種族問題]
** [http://www.sciam.com/article.cfm?chanID=sa006&colID=1&articleID=B0FEC94D-E7F2-99DF-3CD8F25918B63A39 Race in a Bottle, Jonathan Kahn. (Sci Am 2007 Aug)]
** [http://www.sciam.com/article.cfm?chanID=sa006&colID=1&articleID=B0FEC94D-E7F2-99DF-3CD8F25918B63A39 Race in a Bottle, Jonathan Kahn. (Sci Am 2007 Aug)]
** 藥瓶裡的種族問題 科學人 2007 Sep
** 藥瓶裡的種族問題 科學人 2007 Sep
** author: [http://www.hamline.edu/law/facadmin/jonathon_kahn.html Jonathan Kahn]
** author: [http://www.hamline.edu/law/facadmin/jonathon_kahn.html Jonathan Kahn]
* case study #2: CBZ-SJS
 
** [http://explore.pts.org.tw/p2.htm 公視 探索未知世界 第二集: 解毒生命密碼-基因與藥物過敏]
* case study: Diabetes and Diagnosis
** [http://sa.ylib.com/news/newsshow.asp?FDocNo=438&CL=28 嚴重藥物過敏,可以預防 (科學人 2004 May)]
 
** [http://drug.doh.gov.tw/bulletin_cnt.php?PHPSESSID=bg6ksuvuq317fmk4runq4232b6&Pact=bulletin&id=160 我國個人化醫療跨出一大步,讓藥害救濟由事後救濟邁向事前預防 (行政院衛生署藥物資訊網)]
* BioBank and Biomarkers discovery
* Problem definition
 
* Special Solution constructed by BI + MI
** Material and Method
*** Biomarkers discovery
* General solution: ELSI, Biobank and FDA guide lines
* General solution: ELSI, Biobank and FDA guide lines



Revision as of 20:17, 28 September 2007

Title

  • Toward Personalized Medicine in BMI-based Methodology: A case study of Carbamazepine and challenges in the future

Outlines (Sep 27, 2007)

  • case study: Diabetes and Diagnosis
  • BioBank and Biomarkers discovery
  • General solution: ELSI, Biobank and FDA guide lines

Outlines (Sep 20, 2007)

  • BMI = BI + MI
    • what BMI can do
      • Neuroinformatics (NI)
      • Cancer research (CR)
  • Personalized Medicine (PM)

Background

Materials

Notes